Raising Awareness of Pre-Exposure Prophylaxis (PrEP) among Women in New York City: Community and Provider Perspectives

References

• Arnold, E. A., Hazelton, P., Lane, T., Christopoulos, K. A., Galindo, G. R., Steward, W. T., … Lama, J. R. (2012). A qualitative study of provider thoughts on implementing pre-exposure prophylaxis (PrEP) in clinical settings to prevent HIV infection. PLoS One, 7(7), 1–8. doi:10.1371/journal.pone.0040603
   Web of Science ®Google Scholar
• Auerbach, J. D., Kinsky, S., Brown, G., & Charles, V. (2015). Knowledge, attitudes, and likelihood of pre-exposure prophylaxis (PrEP) use among US women at risk of acquiring HIV. AIDS Patient Care & Stds, 29, 102–110. doi:10.1089/apc.2014.0142
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. (2015a). CDC vital signs: Daily pill can prevent HIV. Retrieved from http://www.cdc.gov/vitalsigns/pdf/2015-11-24-vitalsigns.pdf
   Google Scholar
• Centers for Disease Control and Prevention. (2015b). HIV surveillance report, 2014 (Vol. 26). Retrieved from http://www.cdc.gov/hiv/library/reports/surveillance/
   Google Scholar
• Colarossi, L. G., Hazel, D. S., Collier, K. L., DeSouza, S., & Pappas, L. (2016). Research with Latina and Black women for an HIV prevention campaign. Social Marketing Quarterly, 22(3), 236–252. doi:10.1177/1524500416644405
   Web of Science ®Google Scholar
• Edelstein, Z., Mensah, N., Scanlin, K., Cutler, B., & Myers, J. (2014). Awareness of HIV prevention innovations among women of color in NYC: HIV self-tests and pre-exposure prophylaxis (PrEP). Paper presented at the American Public Health Association 142nd Annual Meeting & Expo, New Orleans, LA. Abstract Retrieved from https://apha.confex.com/apha/142am/webprogram/Paper303665.html
   Google Scholar
• Flash, C. A., Stone, V. E., Mitty, J. A., Mimiaga, M. J., Hall, K. T., Krakower, D., & Mayer, K. H. (2014). Perspectives on HIV prevention among urban black women: A potential role for HIV pre-exposure prophylaxis. AIDS Patient Care & Stds, 28, 635–642. doi:10.1089/apc.2014.0003
   PubMed Web of Science ®Google Scholar
• Hoffman, S., Guidry, J. A., Collier, K. L., Mantell, J. E., Boccher-Lattimore, D., Kaighobadi, F., & Sandfort, T. G. M. (2016). A clinical home for preexposure prophylaxis: Diverse health care providers’ perspectives on the “purview paradox.” Journal of the International Association of Providers of AIDS Care, 15, 59–65. doi:10.1177/2325957415600798
   PubMedGoogle Scholar
• Mayer, K. H., Hosek, S., Cohen, S., Liu, A., Pickett, J., Warren, M., … Grant, R. (2015). Antiretroviral pre-exposure prophylaxis implementation in the United States: A work in progress. Journal of the International AIDS Society, 18(Suppl 3), 19980. doi:10.7448/IAS.18.4.19980
   PubMed Web of Science ®Google Scholar
• Mustanski, B., Ryan, D. T., Sanchez, T., Sineath, C., Macapagal, K., & Sullivan, P. S. (2014). Effects of messaging about multiple biomedical and behavioral HIV prevention methods on intentions to use among US MSM: Results of an experimental messaging study. AIDS & Behavior, 18, 1651–1660. doi:10.1007/s10461-014-0811-2
   PubMed Web of Science ®Google Scholar
• New York City Department of Health and Mental Hygiene. (2013). HIV/AIDS Surveillance Data 2013 [Epiquery: NYC Interactive Health Data System]. Retrieved from http://nyc.gov/health/epiquery
   Google Scholar
• Rountree, M. A., Granillo, T., & Bagwell-Gray, M. (2016). Promotion of Latina health: Intersectionality of IPV and risk for HIV/AIDS. Violence Against Women, 22, 545–564. doi:10.1177/1077801215607358
   PubMed Web of Science ®Google Scholar
• Sevelius, J. M., Keatley, J., Calma, N., & Arnold, E. (2016). ‘I am not a man’: Trans-specific barriers and facilitators to PrEP acceptability among transgender women. Global Public Health, 11, 1060–1075. doi:10.1080/17441692.2016.1154085
   PubMed Web of Science ®Google Scholar
• Shaeer, K. M., Sherman, E. M., Shafiq, S., & Hardigan, P. (2014). Exploratory survey of Florida pharmacists’ experience, knowledge, and perception of HIV pre-exposure prophylaxis. Journal of the American Pharmacists Association, 54, 610–617. doi:10.1331/japha.2014.14014
   PubMed Web of Science ®Google Scholar
• Smith, D. K., Pals, S. L., Herbst, J. H., Shinde, S., & Carey, J. W. (2012). Development of a clinical screening index predictive of incident HIV infection among men who have sex with men in the United States. Journal of Acquired Immune Deficiency Syndromes, 60, 421–427. doi:10.1097/QAI.0b013e318256b2f6
   PubMed Web of Science ®Google Scholar
• Smith, D. K., Toledo, L., Smith, D. J., Adams, M. A., & Rothenberg, R. (2012). Attitudes and program preferences of African-American urban young adults about pre-exposure prophylaxis (PrEP). AIDS Education & Prevention, 24, 408–421. doi:10.1521/aeap.2012.24.5.408
   PubMed Web of Science ®Google Scholar
• Smith, D. K., Van Handel, M., Wolitski, R. J., Stryker, J. E., Hall, H. I., Prejean, J., … Valleroy, L. A. (2015). Vital signs: Estimated percentages and numbers of adults with indications for preexposure prophylaxis to prevent HIV acquisition – United States. Morbidity & Mortality Weekly Report, 64, 1291–1295. doi:10.15585/mmwr.mm6446a4
   PubMed Web of Science ®Google Scholar
• Strauss, A., & Corbin, J. (1990). Basics of qualitative research: Grounded theory procedures and techniques. Newbury Park, CA: Sage.
   Google Scholar
• U.S. Public Health Service. (2014). Preexposure prophylaxis for the prevention of HIV infection in the United States – 2014: A clinical practice guideline. Retrieved from http://www.cdc.gov/hiv/pdf/prepguidelines2014.pdf
   Google Scholar
• Underhill, K., Morrow, K. M., Colleran, C., Calabrese, S. K., Operario, D., Salovey, P., & Mayer, K. H. (2015). Explaining the efficacy of pre-exposure prophylaxis (PrEP) for HIV prevention: A qualitative study of message framing and messaging preferences among US men who have sex with men. AIDS & Behavior. doi:10.1007/s10461-015-1088-9
   Web of Science ®Google Scholar
• White House. (2013). Addressing the intersection of HIV/AIDS, violence against women and girls, and gender-related health disparities. Washington, D.C.: Author. Retrieved from https://www.whitehouse.gov/sites/default/files/docs/vaw-hiv_working_group_report_final_-9-6–2013.pdf
   Google Scholar
• White House Office of National AIDS Policy. (2015). National HIV/AIDS strategy for the United States: Updated to 2020. Retrieved from https://www.aids.gov/federal-resources/national-hiv-aids-strategy/nhas-update.pdf
   Google Scholar
• Wingood, G. M., Dunkle, K., Camp, C., Patel, S., Painter, J. E., Rubtsova, A., & DiClemente, R. J. (2013). Racial differences and correlates of potential adoption of preexposure prophylaxis: Results of a national survey. Journal of Acquired Immune Deficiency Syndromes, 63, S95–S101. doi:10.1097/QAI.0b013e3182920126
   PubMedGoogle Scholar
• Wyatt, G. E., Myers, H. F., Williams, J. K., Kitchen, C. R., Loeb, T., Carmona, J. V., … Presley, N. (2002). Does a history of trauma contribute to HIV risk for women of color? Implications for prevention and policy. American Journal of Public Health, 92, 660–665. doi:10.2105/AJPH.92.4.660
   PubMed Web of Science ®Google Scholar
• Yaylali, E., Farnham, P., Jacobson, E., Allaire, B. T., Wagner, D. L., Hicks, K. A., … Sansom, S. L. (2016, February). Impact of improving HIV care and treatment and initiating PrEP in the United States, 2015-2020. Poster presented at the 2016 Conference on Retroviruses and Opportunistic Infections, Boston, MA. Abstract retrieved from http://www.croiconference.org/sessions/impact-improving-hiv-care-and-treatment-and-initiating-prep-united-states-2015-2020
   Google Scholar
• Young, I., & McDaid, L. (2014). How acceptable are antiretrovirals for the prevention of sexually transmitted HIV?: A review of research on the acceptability of oral pre-exposure prophylaxis and treatment as prevention. AIDS & Behavior, 18, 195–216. doi:10.1007/s10461-013-0560-7
   PubMed Web of Science ®Google Scholar